JAMES KELLY: Open Payments
NPI 1356365522 · ROCKY HILL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 10 payments from 9 companies in 2025. Trend: 2023 $71 · 2024 $687 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $122 |
| Lilly USA, LLC | 2 | $45 |
| Amgen Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Abbott Laboratories | 1 | $14 |
Products named: Auvelity, MOUNJARO, REPATHA, LEQVIO, YUPELRI, TRELEGY ELLIPTA, Wegovy, VRAYLAR.
Industry payments across CT — which companies pay providers there.
